.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The landscape of alopecia areata management is evolving rapidly within the Asia-Pacific region. Recently, a modified Delphi expert panel consisting of 18 dermatologists from eight countries, including India, provided updated recommendations. These guidelines help clinicians navigate the clinical heterogeneity of the disease. Moreover, they address the significant quality-of-life impact that hair loss imposes on patients and their families.
The panel emphasizes that trichoscopy is an essential tool for both diagnosis and ongoing monitoring. Specifically, clinicians should use it to identify pathognomonic markers such as black dots, yellow dots, and tapering hairs. However, experts suggest that skin biopsy is not necessary for every patient. Instead, doctors should reserve this procedure for cases where the underlying cause of hair loss remains unclear or diagnostic uncertainty persists.
Consistency in staging is vital for effective treatment planning. Consequently, the panel defines moderate alopecia areata as 21% to 49% scalp involvement. They classify cases with 50% or more hair loss as severe. This distinction is critical because it dictates the choice between topical and systemic interventions. For instance, topical corticosteroids remain the primary recommendation for pediatric patients. Furthermore, the consensus incorporates recently approved systemic treatments, providing a roadmap for modern clinical practice in India and across the APAC region.
The Asia-Pacific consensus defines moderate disease as 21% to 49% hair loss. Severe cases involve 50% or more of the scalp.
No, a biopsy is not routine. Clinicians primarily use trichoscopy for diagnosis and only use biopsy when the cause of hair loss is uncertain.
The panel suggests topical corticosteroids as the preferred initial treatment for pediatric patients.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always seek the advice of a qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new APAC expert consensus defines severity and emphasizes trichoscopy for effective alopecia areata management in children and adults....
5 months ago
A landmark study reveals that Milk Fat Globule-EGF Factor 8 (MFG-E8) protects hepatocytes from ferroptotic death and preserves epithelial integrity during liver injury, highlighting novel therapeutic targets for hepatic regeneration and acute liver failure management.
Today
A prospective study evaluates the fetal Evans Index in late-onset fetal growth restriction, uncovering anterior cerebral remodeling rather than ventriculomegaly, with conventional growth metrics retaining primary prognostic power for neonatal intensive care unit admission.
Today
Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today
Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today
Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today
